Skip to main content

Paroxetine in the treatment of generalised anxiety disorder.

Publication ,  Journal Article
Snyderman, SH; Rynn, MA; Bellew, K; Rickels, K
Published in: Expert Opin Pharmacother
August 2004

Paroxetine is a selective serotonin re-uptake inhibitor useful in the treatment of a wide range of psychiatric disorders. Generalised anxiety disorder (GAD) is characterised by excessive persistent anxiety and worry about a number of events and activities occurring on more days than not for at least 6 months. GAD is the most common anxiety disorder in primary care settings. Paroxetine was the second antidepressant to receive an FDA indication for the treatment of GAD. In contrast to benzodiazepines, which had been the mainstay of treatment for anxiety disorders for many years, antidepressants, such as paroxetine, are more effective for the psychic symptoms of anxiety, which include worry, tension, irritability and concentration difficulties, and carry a more tolerable and safe side effect profile.

Duke Scholars

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

August 2004

Volume

5

Issue

8

Start / End Page

1799 / 1806

Location

England

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Pharmacology & Pharmacy
  • Paroxetine
  • Humans
  • Delayed-Action Preparations
  • Buspirone
  • Benzodiazepines
  • Anxiety Disorders
  • Antidepressive Agents, Tricyclic
  • Antidepressive Agents, Second-Generation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Snyderman, S. H., Rynn, M. A., Bellew, K., & Rickels, K. (2004). Paroxetine in the treatment of generalised anxiety disorder. Expert Opin Pharmacother, 5(8), 1799–1806. https://doi.org/10.1517/14656566.5.8.1799
Snyderman, Steven H., Moira A. Rynn, Kevin Bellew, and Karl Rickels. “Paroxetine in the treatment of generalised anxiety disorder.Expert Opin Pharmacother 5, no. 8 (August 2004): 1799–1806. https://doi.org/10.1517/14656566.5.8.1799.
Snyderman SH, Rynn MA, Bellew K, Rickels K. Paroxetine in the treatment of generalised anxiety disorder. Expert Opin Pharmacother. 2004 Aug;5(8):1799–806.
Snyderman, Steven H., et al. “Paroxetine in the treatment of generalised anxiety disorder.Expert Opin Pharmacother, vol. 5, no. 8, Aug. 2004, pp. 1799–806. Pubmed, doi:10.1517/14656566.5.8.1799.
Snyderman SH, Rynn MA, Bellew K, Rickels K. Paroxetine in the treatment of generalised anxiety disorder. Expert Opin Pharmacother. 2004 Aug;5(8):1799–1806.

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

August 2004

Volume

5

Issue

8

Start / End Page

1799 / 1806

Location

England

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Pharmacology & Pharmacy
  • Paroxetine
  • Humans
  • Delayed-Action Preparations
  • Buspirone
  • Benzodiazepines
  • Anxiety Disorders
  • Antidepressive Agents, Tricyclic
  • Antidepressive Agents, Second-Generation